Myasthenia gravis
2007

Understanding Myasthenia Gravis

publication Evidence: moderate

Author Information

Author(s): Juel Vern C, Massey Janice M

Primary Institution: Duke University Medical Center

Conclusion

Myasthenia gravis is a rare autoimmune disorder that leads to fluctuating muscle weakness, but with improved diagnosis and treatment, the prognosis is now favorable.

Supporting Evidence

  • Contemporary prevalence rates of myasthenia gravis approach 1 in 5,000.
  • Less than five percent of patients with myasthenia gravis experience mortality.
  • Improved diagnostic testing and immunotherapy have led to nearly normal life expectancy for patients.

Takeaway

Myasthenia gravis is a condition that makes your muscles weak and tired, but doctors have found ways to help people feel better.

Methodology

The article reviews the clinical features, diagnostic criteria, and treatment options for myasthenia gravis.

Participant Demographics

The onset of myasthenia gravis is influenced by age and gender, with women predominating under 40 and men slightly more common after 50.

Digital Object Identifier (DOI)

10.1186/1750-1172-2-44

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication